Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

- Lorscheider, J., Kuhle, J., Grand'Maison, F., Grammond, P., Sola, P., Ferraro, D., Trojano, M., Ramo-Tello, C., Lechner-Scott, J., Pucci, E., Solaro, C., Slee, M., Izquierdo, G., Van Pesch, V., Sanchez Menoyo, J. L., van der Walt, A., Butzkueven, H., Kappos, L., Kalincik, T., Lugaresi, A., Havrdova, E., Horakova, D., Hupperts, R., Duquette, P., Girard, M., Prat, A.

The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude

- Lechner-Scott, J., Spencer, B., Girard, M., Grammond, P., Oreja-Guevara, C., Hupperts, R., Bergamaschi, R., Boz, C., Giuliani, G., Van Pesch, V., Iuliano, G., Fiol, M., De Malmanche, T., Attia, J.R., Fitzgerald, M., Trojano, M., Grand'Maison, F., Antonio C Gomez, J., Izquierdo, G., Duquette, P.